title: Monitoring CML after nonmyeloablative transplantations: how negative is negative?
authors.forename: Jaspal
authors.initials: J
authors.lastname: Kaeda
authors.forename: Jane
authors.initials: J
authors.lastname: Apperley
authors.forename: Junia
authors.initials: J
authors.lastname: Melo
authors.forename: Nicolas
authors.initials: N
authors.lastname: Cross
authors.forename: John
authors.initials: J
authors.lastname: Goldman
mesh_terms: D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D012333:RNA, Messenger / Q000032:analysis; D033581:Stem Cell Transplantation
chemical_list: D012333:RNA, Messenger; D016044:Fusion Proteins, bcr-abl